Patent · US Active

Sulfonamide anti-viral compounds

US8895608B2 · kind B2 · utility

5Cited by

1References

7Claims

0Family size

Assignee

Kineta, Inc. · US

Inventors

Shawn P. Iadonato · Seattle, US
Kristin Bedard · Bellevue, US

Key dates

Filing date	Apr 20, 2011
Grant date	Nov 25, 2014
Priority date	—
Expiry date	May 20, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds and related compositions for the treatment of viral infection, including RNA viral infection, and compounds that can modulate the RIG-I pathway in vertebrate cells, including compounds that can activate the RIG-I pathway.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.